A war of words is simmering between the Chilean government and the pharmaceutical industry over steps the South American country is considering to control rising drug costs.
In recent remarks, Jose Ramon Valente Vias, the minister of Economy, Development, and Tourism, pushed back against the latest effort by the PhRMA industry trade group to convince the U.S. Trade Representative to keep Chile on its annual list of countries that fail to protect and enforce patent rights. The U.S. Trade Rep is due to release its latest so-called U.S. Priority Watch list shortly.
About the Author Reprints
